Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9VZQ

Crystal structure of RORgamma in complex with novel inverse agonist

Summary for 9VZQ
Entry DOI10.2210/pdb9vzq/pdb
DescriptorNuclear receptor ROR-gamma, Nuclear receptor coactivator 1, (25R)-14beta,17beta-spirost-5-en-3beta-ol, ... (4 entities in total)
Functional Keywordsinverse agonist, transcription
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight30554.52
Authors
Chen, S.M.,Tian, S.Y.,Li, Y. (deposition date: 2025-07-23, release date: 2026-06-03)
Primary citationChen, S.,Tian, S.,Liang, J.,Wang, R.,Li, Y.
Structural basis for diosgenin as an inverse agonist of retinoic acid receptor-related orphan receptor gamma.
Sci Rep, 16:4765-4765, 2026
Cited by
PubMed Abstract: Retinoic acid receptor-related orphan receptor γ (RORγ) is a member of the nuclear receptor superfamily involved in many physiological activities such as metabolic and autoimmune diseases, and therefore a potential therapeutic drug target. Here we report that the steroidal sapogenin, diosgenin, a novel ligand for RORγ, inhibits the transcriptional activity of the RORγ with distinctive properties in coregulator recruitment. Biochemical and cell-based studies indicated that diosgenin functions as a selective RORγ inverse agonist by inducing both coactivator and corepressor binding to RORγ, thereby uncovering a molecular mechanism for the actions of this natural compound. Further, the crystal structure of diosgenin complexed with the ligand-binding domain of RORγ reveals a unique binding mode including the active conformation of AF-2 helix and the conformational shift of Helix 11. Structural and functional studies suggest the plasticity of RORγ pockets in recognizing ligands and the vital roles of the backbone of diosgenin in recognizing RORγ. Our results provide a unique inverse agonist template of RORγ with high selectivity and efficacy, which contributes to further drug design and optimization targeting RORγ.
PubMed: 41495387
DOI: 10.1038/s41598-026-35006-6
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.18 Å)
Structure validation

254587

PDB entries from 2026-06-03

PDB statisticsPDBj update infoContact PDBjnumon